Lactiplantibacillus plantarum LP01™ (LMG P-21021) (formerly Lactobacillus plantarum)
Allergy & Immunology
Respiratory/ Immune health
May support a healthy response to respiratory pathogens [in vitro]
Single strain
Blend
Finished dosage form
a) Visciglia A. et al. Probiotics: a potential therapeutic strategy in respiratory infections. Poster from the 12th Probiotics, Prebiotics & New Foods, Nutraceutical and Botanicals for Nutrition & Human and Mirobiota Health, held in Rome on 12-14 September 2021
b) Amoruso A. et al. A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus plantarum LP01 (LMG P-21021). J Prob Health. 2019; 7:214. Doi: 10.35248/2329-8901.19.7.214
For information on blends containing LP01™ see the following Blends and Products pages:
- BIFIVIR®
- FLOR-EN® ADULTS
- ALLERFLORA®
- BIFICOL®
- PROBIAL® Stomach
- ACTIVAG®
- PROBIAL® Age
- Bifizen®
- ALITOLACTIS®
- BIFICIST®
- BIFIPROST®
- PROBIAL® ASD
- PROBIAL® FLAT BELLY
- LP01™ + LDD01, LR06, LPS01 + NAC
- LP01™ + LF10, LDD01, LS03, ST10
- LP01™ + LLC02 + LDD01
Gastroenterology
INTESTINAL TRANSIT/OCCASIONAL CONSTIPATION/GUT DYSBIOSIS
Reduces occasional constipation
Supports healthy intestinal transit time
Inhibits GI pathogens [in vitro]
Supports a healthy immune response [in vitro]
1) 10 billion CFU
Single strain
Blend
Finished dosage form
1) Del Piano M. et al. The use of probiotics in the treatment of constipation in the elderly. CIBUS, 2005; 1(1):23-30.
a) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32. Doi: 10.1097/MCG.0b013e31826852b7
b) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
c) Amoruso A. et al. A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus plantarum LP01 (LMG P-21021). J Prob Health. 2019; 7:214. Doi: 10.35248/2329-8901.19.7.214
Further internal data on anti-inflammatory activity and intestinal barrier are available upon request.
For information on blends containing LP01™ see the Blends and Products pages listed above
Gastroenterology
GUT MICROBIOME DYSBIOSIS
Inhibits pathogenic E. coli, E. faecalis, K. pneumoniae, S. aureus and/or P. aeruginosa [in vitro]
Single strain
Blend
Finished dosage form
a) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32. Doi: 10.1097/MCG.0b013e31826852b7
b) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
For information on blends containing LP01™ see the Blends and Products pages listed above
Gastroenterology
DETOXIFICATION/BIOSEQUESTRATION
May support healthy detoxification processes [in vitro]
May support healthy responses to environmental toxins [in vitro]
Single strain
Blend
Finished dosage form
a) Rapacioli S, et al. Innovative Perspectives on the detoxifying effects of lactobacillus probiotic strains. Poster from the 12th Probiotics, Prebiotics & New Foods, Nutraceutical and Botanicals for Nutrition & Human and Microbiota Health, held in Rome on 12-14 September 2021.
For information on blends containing LP01™ see the Blends and Products pages listed above
Neurology
Mood / Sleep Quality
Supports healthy sleep
Supports a healthy mood
Blend
Finished dosage form
a) Visciglia A., et al. Probiotics and Gut-Brain Axis: Insights on local and systemic mechanisms of action. Poster from the 12th Probiotics, Prebiotics & New Foods, Nutraceutical and Botanicals for Nutrition & Human and Microbiota Health, held in Rome on 12-14 September 2021.
For information on blends containing LP01™ see the Blends and Products pages listed above
Neurology
PARKINSON’s DISEASE
Supports a healthy immune response in cells of patients with Parkinson’s Disease [in vitro]
Single strain
Blend
Finished dosage form
a) Magistrelli L. et al. Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence. Front Immunol. 2019 May 7;10:969. doi: 10.3389/fimmu.2019.00969
For information on blends containing LP01™ see the Blends and Products pages listed above
Neurology
Neurotransmitter synthesis
Strain-specific GABA production capability [in vitro]
Single strain
a) De Prisco A. et al. Strain-specific Production of GABA by Lactobacilli and Bifidobacteria Probiotics. Poster from the 15th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health – IPC2022, held in Bratislava on 27-30 June 2022.
For information on blends containing LP01™ see the Blends and Products pages listed above
Urology
URINARY TRACT HEALTH
Inhibits pathogenic E. coli [in vitro]
May promote a healthy response to pathogens [in vitro]
Blend
Finished dosage form
a) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32. Doi: 10.1097/MCG.0b013e31826852b7
b) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
c) Amoruso A. et al. (2019) A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus plantarum LP01 (LMG P-21021). J Prob Health. 7:214. Doi: 10.35248/2329-8901.19.7.214
For information on blends containing LP01™ see the Blends and Products pages listed above
